Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib
Br J Haematol
.
2024 Apr 25.
doi: 10.1111/bjh.19483.
Online ahead of print.
Authors
Irene Trambusti
1
,
Francesco Pegoraro
1
2
,
Stefania Gaspari
3
,
Fabiola Dell'Acqua
4
,
Monica Cellini
5
,
Antonino Trizzino
6
,
Annalisa Tondo
1
,
Anna Perrone
7
,
Maria Luisa Coniglio
1
,
Renzo Guerrini
8
9
,
Carmen Barba
8
9
,
Elena Sieni
1
Affiliations
1
Pediatric Hematology-Oncology Department, Meyer Children's Hospital IRCCS, Florence, Italy.
2
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
3
Pediatric Hematology/Oncology Department, Cell and Gene Therapy, Scientific Institute for Research, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
4
Pediatric Hematology-Oncology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
5
Pediatric Hematology Oncology Department, Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy.
6
Pediatric Hemato-Oncology Department, ARNAS Ospedali Civico, G. Di Cristina, Palermo, Italy.
7
Pediatric Radiology Department, Meyer Children's Hospital IRCCS, Florence, Italy.
8
Neuroscience Department, Meyer Children's Hospital IRCCS, Florence, Italy.
9
Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
PMID:
38665038
DOI:
10.1111/bjh.19483
No abstract available
Publication types
Letter